The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study
- PMID: 25440091
- PMCID: PMC4610345
- DOI: 10.1016/j.jacc.2014.08.035
The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study
Abstract
Background: Left ventricular (LV) trabeculation is highly variable among individuals and is increased in some diseases (e.g., congenital heart disease or cardiomyopathies), but its significance in population-representative individuals is unknown.
Objectives: The goal of this study was to determine if excessive LV trabeculation in population-representative individuals is associated with preceding changes in cardiac volumes and function.
Methods: For technical reasons, the extent of trabeculation, which is expressed as the ratio of noncompacted to compacted (NC/C) myocardium, was measured on cardiac magnetic resonance (CMR) long-axis cine images in 2,742 participants in the MESA (Multi-Ethnic Study of Atherosclerosis) (mean age 68.7 years; 52.3% women; 56.4% with hypertension; 16.8% with diabetes) at examination 5. These were considered in quintiles of trabeculation extent; the NC/C ratio of quintile 5 was 2.46 to 5.41. We determined the relationship between the maximal NC/C ratio and the preceding change (9.5 years between examinations 1 and 5) in end-systolic volume indexed (ESVi) to body surface area. Secondary analyses assessed the associations between the maximal NC/C ratio and preceding changes in end-diastolic volume indexed (EDVi) to body surface area and the ejection fraction (EF).
Results: Over 9.5 years, the ESVi decreased by 1.3 ml/m(2), the EDVi decreased by 5.1 ml/m(2), and the EF decreased by 0.6% (p < 0.0001). Even in subjects with excessive trabeculation, there were no clinically relevant differences in LV volumes and systolic function changes among the quintiles of trabeculation extent.
Conclusions: Greater extent of, and even excessive, LV trabeculation measured in end-diastole in asymptomatic population-representative individuals appeared benign and was not associated with deterioration in LV volumes or function during an almost 10-year period.
Keywords: cardiac magnetic resonance; left ventricular function; left ventricular trabeculations.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Left ventricular noncompaction: a genetic cardiomyopathy looking for diagnostic criteria.J Am Coll Cardiol. 2014 Nov 11;64(19):1981-3. doi: 10.1016/j.jacc.2014.08.034. Epub 2014 Nov 3. J Am Coll Cardiol. 2014. PMID: 25440092 No abstract available.
-
[Comment on "The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5 year follow-up. The MESA study"].Rev Port Cardiol. 2015 Feb;34(2):147-9. doi: 10.1016/j.repce.2015.02.003. Rev Port Cardiol. 2015. PMID: 25834860 Portuguese. No abstract available.
References
-
- Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J. 2008;29:89–95. - PubMed
-
- Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000;36:493–500. - PubMed
-
- Ritter M, Oechslin E, Sütsch G, Attenhofer C, Schneider J, Jenni R. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997;72:26–31. - PubMed
-
- Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46:101–105. - PubMed
-
- Jacquier A, Thuny F, Jop B, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J. 2010;31:1098–1104. - PubMed
Publication types
MeSH terms
Grants and funding
- N01-HC-95162/HC/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- FS/12/56/29723/BHF_/British Heart Foundation/United Kingdom
- UL1-TR-000040/TR/NCATS NIH HHS/United States
- N01-HC-95160/HC/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- FS/10/40/28260/BHF_/British Heart Foundation/United Kingdom
- UL1 RR025005/RR/NCRR NIH HHS/United States
- UL1-RR-025005/RR/NCRR NIH HHS/United States
- N01-HC-95163/HC/NHLBI NIH HHS/United States
- N01-HC-95168/HC/NHLBI NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- N01-HC-95169/HC/NHLBI NIH HHS/United States
- N01-HC-95164/HC/NHLBI NIH HHS/United States
- MR/K006584/1/MRC_/Medical Research Council/United Kingdom
- N01 HC095168/HC/NHLBI NIH HHS/United States
- N01-HC-95161/HC/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- N01 HC095162/HL/NHLBI NIH HHS/United States
- N01-HC-95166/HC/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
- N01-HC-95167/HC/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
